(Q44230417)

1 December 2017

Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL. (English)

1 reference

1 December 2017

1 reference

3

1 reference

1 December 2017

5

1 reference

1 December 2017

Arianna Gonelli

1

0 references

author name string

Oriano Radillo

series ordinal

2

1 reference

PubMed ID

21125311

1 December 2017

Erika Rimondi

series ordinal

4

1 reference

PubMed ID

21125311

1 December 2017

Gian Maria Bonora

series ordinal

6

1 reference

1 December 2017

2 December 2010

1 reference

Investigational New Drugs

1 December 2017

1 reference

1 December 2017

30

1 reference

1 December 2017

2

1 reference

1 December 2017

828-832

1 reference

https://scigraph.springernature.com/pub.10.1007/s10637-010-9599-8

1 December 2017

0 references

cites work

Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

Site-specific PEGylation of native disulfide bonds in therapeutic proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

Improved antitumor activity and tumor targeting of NH(2)-terminal-specific PEGylated tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9599-8

TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells

21 January 2018

1 reference

12 December 2020

Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice

1 reference

12 December 2020

Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer

1 reference

12 December 2020

Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells

1 reference

12 December 2020

Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety

1 reference

12 December 2020

TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release

1 reference

12 December 2020

Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells

1 reference

12 December 2020

Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture

1 reference

12 December 2020

10.1007/S10637-010-9599-8

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

21125311